Log In
Print
BCIQ
Print
Print this Print this
 

Intercept Blood System for red blood cells

  Manage Alerts
Collapse Summary General Information
Company Cerus Corp.
DescriptionPathogen inactivation system using S-303 pH-activated compound
Molecular Target DNA ; RNA
Mechanism of Action 
Therapeutic ModalityMedical Devices

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today